Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemay007 in moderate to severe active rheumatoid arthritis
CTR20201916Phase 2Active
- Sponsor
- Xiajiang Hemei Pharmaceutical
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hemay007 in rheumatoid arthritis (RA), sponsored by Xiajiang Hemei Pharmaceutical. Started Apr 2021; status: active.
02
Drugs
hemay007
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20201916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201916.